The Scientific Committee on Emerging and Newly Identified Health Risks of the European Commission has issued a report on the safety of PIP silicone breast implants.  This concludes that “The limited clinical data, along with the absence of epidemiologic data on PIP silicone breast implants provide insufficient evidence to warrant a conclusion that women with PIP silicone breast implants have a greater risk to their health than women with breast implants from other manufacturers.”

The report does however note that the possibility for health effects cannot be ruled out, and that further work is proposed to establish with greater certainty the health risks, if any, that may be associated with PIP silicone breast implants.

The full report can be accessed via the link below.